Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ZIM LABORATORIES   TEVA PHARMA
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-23
TEVA PHARMA
Dec-13
ZIM LABORATORIES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3883,489-   
Low Rs673,031-   
Sales per share (Unadj.) Rs81.82,002.4-  
Earnings per share (Unadj.) Rs5.0125.1-  
Cash flow per share (Unadj.) Rs8.6286.9-  
Dividends per share (Unadj.) Rs0109.50-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs41.12,224.3-  
Shares outstanding (eoy) m48.73848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.81.6 171.0%   
Avg P/E ratio x45.426.1 174.2%  
P/CF ratio (eoy) x26.511.4 233.1%  
Price / Book Value ratio x5.51.5 377.9%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m11,0962,764,488 0.4%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m4930-   
Avg. sales/employee Rs Th037,780.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,360.1-  
INCOME DATA
Net Sales Rs m3,9851,698,047 0.2%  
Other income Rs m640-   
Total revenues Rs m4,0491,698,047 0.2%   
Gross profit Rs m520465,011 0.1%  
Depreciation Rs m175137,255 0.1%   
Interest Rs m5633,352 0.2%   
Profit before tax Rs m354294,404 0.1%   
Minority Interest Rs m01,337 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-193,260 -0.0%   
Tax Rs m109-3,594 -3.0%   
Profit after tax Rs m244106,076 0.2%  
Gross profit margin %13.027.4 47.6%  
Effective tax rate %30.9-1.2 -2,530.0%   
Net profit margin %6.16.2 98.1%  
BALANCE SHEET DATA
Current assets Rs m1,9091,146,855 0.2%   
Current liabilities Rs m1,1081,000,154 0.1%   
Net working cap to sales %20.18.6 232.8%  
Current ratio x1.71.1 150.3%  
Inventory Days Days1991 21.5%  
Debtors Days Days87296 909.5%  
Net fixed assets Rs m1,569554,620 0.3%   
Share capital Rs m4874,180 11.7%   
"Free" reserves Rs m1,5160-   
Net worth Rs m2,0031,886,208 0.1%   
Long term debt Rs m246868,249 0.0%   
Total assets Rs m3,4793,880,582 0.1%  
Interest coverage x7.39.8 74.7%   
Debt to equity ratio x0.10.5 26.7%  
Sales to assets ratio x1.10.4 261.8%   
Return on assets %8.63.6 240.1%  
Return on equity %12.25.6 216.9%  
Return on capital %18.24.9 368.9%  
Exports to sales %81.10-   
Imports to sales %12.20-   
Net fx Rs m2,7960-   
CASH FLOW
From Operations Rs m375270,581 0.1%  
From Investments Rs m-362-95,878 0.4%  
From Financial Activity Rs m5-324,580 -0.0%  
Net Cashflow Rs m30-149,877 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.59 Rs / USD

Compare ZIM LABORATORIES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ZIM LABORATORIES With: HINDUSTAN BIOSCIE  CHANDRA BHAGAT PHARMA  ADVANCED ENZYME TECHNOLOGIES  EARUM PHARMACEUTICALS  KREBS BIOCHEMICALS  



Today's Market

Sensex Today Trades Lower | Nifty Below 22,150 | Vodafone Idea Falls 3%, TCS 2% Sensex Today Trades Lower | Nifty Below 22,150 | Vodafone Idea Falls 3%, TCS 2%(10:30 am)

Asian markets extended decline and traded lower on Tuesday ahead of key economic data from China and as geopolitical tension intensified in the Middle East.